Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

1
Leucadia National (JEF): An Off-the-Radar Potential Winner

2018-07-06 zacks
It commonly happens in stock investing that investors miss the chance of buying winning stocks that they knew would stand out. Before they take the plunge, others get to know the hidden potential and enter into these stocks, pushing them out of reach. So, instead of repenting, spotting the off-the-radar potential winners and immediately investing in them could be a smart decision. One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is Leucadia National Corporation (JEF - Free Report) .
LUK ENPH

1
LUK / Leucadia National Corp. JEFFERIES FINANCIAL GROUP INC. 8-K (Current Report)

2018-06-19 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
LUK

26
Alliance Data Systems Is A Buy

2018-06-15 seekingalpha
I think shares of Alliance Data Systems represent good value at these levels for a few reasons.
LUK ADS

1
LUK / Leucadia National Corp. FORM 8-K (Current Report)

2018-06-11 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K
LUK

1
LUK / Leucadia National Corp. / First Pacific Advisors, LLC - 13G JEFFERIES FINANCIAL GROUP INC (Passive Investment)

2018-06-08 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. _ _)* Jefferies Financial Group Inc. (Name of Issuer) Common Stock (Title of Class Securities) 47233W109 (CUSIP Number) May 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person?s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosure provided in a pri
LUK

2
LUK / Leucadia National Corp. / First Pacific Advisors, LLC - 13G JEFFERIES FINANCIAL GROUP INC (Passive Investment)

2018-06-08 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. _ _)* Jefferies Financial Group Inc. (Name of Issuer) Common Stock (Title of Class Securities) 47233W109 (CUSIP Number) May 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person?s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosure provided in a pri
LUK

1
LUK / Leucadia National Corp. / First Pacific Advisors, LLC - LEUCADIA NATIONAL CORP. 13G/A 6/8/18 (Passive Investment)

2018-06-08 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. _2 _)* Leucadia National Corporation (Name of Issuer) Common Stock (Title of Class Securities) 527288104 (CUSIP Number) May 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person?s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosure provided in a pri
LUK

1
LUK / Leucadia National Corp. / First Pacific Advisors, LLC - LEUCADIA NATIONAL CORP. 13G/A 6/8/18 (Passive Investment)

2018-06-08 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. _2 _)* Leucadia National Corporation (Name of Issuer) Common Stock (Title of Class Securities) 527288104 (CUSIP Number) May 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person?s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosure provided in a pri
LUK

8
Should You Get Rid of Leucadia National (JEF) Now?

2018-05-31 zacks
Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security before more losses hit your portfolio. One such stock that you may want to consider dropping is Leucadia National Corporation (JEF - Free Report) , which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year.
IMMR ALIMR LUK UPLD

80
Tracking Bruce Berkowitz's Fairholme Portfolio - Q1 2018 Update

2018-05-29 seekingalpha
The portfolio is very concentrated, with St. Joe Companies, Sears Holdings, and its spinoff Seritage Growth Properties forming almost 90% of the entire portfolio.
VST OAK FNMA SHLD FMCKI FMCKJ LUK FNMAS OAK.PRA CLPPZ SRG.PRA JEF FOCIX IPMLF CLPR III FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP JOE FMCKM FMCKN FMCKK VSTO FMCKL BRS FAAFX VST.WSA SRG T FMCC FAIRX VSTE SHLDW FMCCS FMCCT

1
LUK / Leucadia National Corp. 8-K (Current Report)

2018-05-28 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549
LUK

1
LUK / Leucadia National Corp. 8-K (Current Report)

2018-05-27 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549
LUK

17
Leucadia National (LUK) Renamed as Jefferies Financial Group

2018-05-25 zacks
Leucadia National Corporation has been renamed as Jefferies Financial Group Inc. (JEF) effective immediately, after receiving a green signal from its shareholders. Following the name change,Jefferies Financial Group will use the ticker “JEF” for trading purposes on the New York Stock Exchange.
LUK RAVN DTK UTX DHR TLRD

132
GameStop: Great Buy, Great Dividend, Nothing Like Blockbuster

2018-05-23 seekingalpha
In my view, investors would be wise to buy GameStop at these levels. The dividend yield is very generous and is well covered by free cash flow.
LUK AMZN T BBY GME WMT

36
Valuation Dashboard: Financials And Real Estate - Update

2018-05-09 seekingalpha
This article series provides a monthly dashboard of industries in each sector of the GICS classification. It compares valuation and quality factors relative to their historical averages.
SCHW.PRBCL LUK BK ETFC SIVB

Related Articles

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

NVRO: Nevro Corp Analysis and Research Report

2018-07-06 - Asif

Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...

Silicon Investor Message Boards

This table lists all message boards related to LUK / Leucadia National Corp. on message board site Silicon Investor.

Leucadia National Corp. (LUK) Russian Stocks : Lukoil, Yukos, VIP, ROS, ...
Tim Luke Dead? Tim Luke Petition to Unsuspend Him
Sibneft, perhaps a new Lukoil Tim Luke Banned for Life - Letu0027s Talk About It
LUKOY The largest oil company in the world LukOil unknown Tim Luke Alive?
Where is Tim Luke ? Letu0027s help Tim Luke and Booray be reinstated
CUSIP: 527288104